COMMUNIQUÉS West-GlobeNewswire

Athenex, Inc. to Report First Quarter Earnings Results on May 14, 2018
03/05/2018
BUFFALO, N.Y., May 03, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
T2 Biosystems Reports Granting of Inducement Awards
03/05/2018
LEXINGTON, Mass., May 03, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO ), an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in [...]
Fibrocell to Host Conference Call and Webcast on Thursday, May 10, 2018 to Discuss First Quarter 2018 Financial Results and Recent Highlights
03/05/2018
EXTON, Pa., May 03, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC ), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, will [...]
VANC Pharmaceuticals’ Vision for a New Future
03/05/2018
VANCOUVER, British Columbia, May 03, 2018 (GLOBE NEWSWIRE) -- VANC Pharmaceuticals Inc. ( “VANC” ) (TSXV:VANC) (OTCQB:NUVPF) Board of Directors provided guidance on future company direction and initiatives today. “In [...]
Opiant Pharmaceuticals To Host Key Opinion Leader Meeting on Medications for Addictions and Related Disorders
03/05/2018
Key Opinion Leader Luncheon to Take Place in New York City on May 10 SANTA MONICA, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") (NASDAQ: OPNT ), a specialty pharmaceutical company [...]
Caladrius Biosciences to Host First Quarter 2018 Financial Results Conference Call on Thursday, May 10, 2018 at 4:30 p.m. Eastern Time
03/05/2018
BASKING RIDGE, N.J., May 03, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS ) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms [...]
Catalyst Biosciences Reports First Quarter Operating & Financial Results and Provides Corporate Update
03/05/2018
Announced Korean Ministry of Food and Drug Safety approval to add sixth cohort to the Phase 1/2 trial of CB 2679d/ISU304 in individuals with hemophilia B Raised approximately $106.8 million in an underwritten public [...]
Syneos Health Leaders Honored by the Healthcare Businesswomen’s Association
03/05/2018
RALEIGH, N.C., May 03, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq: SYNH ), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and CCO (Contract [...]
Key Biologics Accelerates CAR-T Research with New Leukaphereses Offerings
03/05/2018
Also announces installation of Asymptote VIA Quad Freeze controlled-rate freezer MEMPHIS, Tenn. and MONTREAL, May 03, 2018 (GLOBE NEWSWIRE) -- Key Biologics LLC , a provider of biological raw materials and services for [...]
GW Pharmaceuticals to Report Second Quarter Financial Results and Host Conference Call on 8 May, 2018
03/05/2018
LONDON, May 03, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH ) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its [...]
Strongbridge Biopharma plc Announces New Employment Inducement Awards
03/05/2018
DUBLIN, Ireland and TREVOSE, Pa., May 03, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP ), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]
Minerva Neurosciences Reports First Quarter 2018 Financial Results and Business Updates
03/05/2018
WALTHAM, Mass., May 03, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV ), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) [...]
Kura Oncology to Present at Deutsche Bank 43rd Annual Health Care Conference
03/05/2018
SAN DIEGO, May 03, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA ), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced its [...]
Avenue Therapeutics Reports First Quarter 2018 Financial Results and Recent Corporate Highlights
03/05/2018
Completed enrollment in Phase 3 trial of IV tramadol for the treatment of postoperative pain following bunionectomy surgery; topline data expected in second quarter 2018 NEW YORK, May 03, 2018 (GLOBE NEWSWIRE) -- Avenue [...]
Immunovaccine Inc. Has Applied to List its Common Shares on Nasdaq, Announces Reverse Stock Split
03/05/2018
HALIFAX, Nova Scotia, May 03, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (“Immunovaccine” or the “Corporation”) (TSX: IMV ) (OTCQX:IMMVF), a clinical stage immunotherapy company, announced today that it has applied to [...]
Neuralstem Announces Publication of Long-Term Follow-up Data on ALS in the Annals of Clinical and Translational Neurology
03/05/2018
Post-hoc comparison of combined cohorts from Phase 1 and 2 trials vs. historical controls revealed statistically significant difference in scores in functional status and in a composite statistic combining survival and [...]
Intra-Cellular Therapies Reports First Quarter 2018 Financial Results and Provides Corporate Update
03/05/2018
NEW YORK, May 03, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI ), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]
Codexis to Hold First Quarter 2018 Conference Call on May 10
03/05/2018
REDWOOD CITY, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS ), a leading protein engineering company, announces that it will report first quarter 2018 financial results after market close on [...]
PetVivo Holdings, Inc. Provides Shareholders Update
03/05/2018
MINNEAPOLIS, May 03, 2018 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCMarkets:PETV), an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for pets is [...]

Pages